Could a stockroom be the next great scientific revolution?

June 13, 2013

Kevin Munnelly is the President and CEO of Gen9, a company founded by some of the biggest names in synthetic biology research to commercialize a better way of synthesizing DNA. In a recent article published in the journal ACS Synthetic Biology, Munnelly outlines the transformative potential of the field and identifies a key obstacle standing in its way: standardization. (Wired)